493 related articles for article (PubMed ID: 10557071)
21. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
22. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
23. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
[TBL] [Abstract][Full Text] [Related]
24. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.
Bradley G; Irish J; MacMillan C; Mancer K; Witterick I; Hartwick W; Gullane P; Kamel-Reid S; Benchimol S
Oncogene; 2001 Feb; 20(5):654-8. PubMed ID: 11313998
[TBL] [Abstract][Full Text] [Related]
25. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
[TBL] [Abstract][Full Text] [Related]
26. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
[TBL] [Abstract][Full Text] [Related]
27. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
[TBL] [Abstract][Full Text] [Related]
29. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
30. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM
Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158
[TBL] [Abstract][Full Text] [Related]
31. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
32. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
Grüttgen A; Reichenzeller M; Jünger M; Schlien S; Affolter A; Bosch FX
J Pathol; 2001 Jul; 194(3):311-7. PubMed ID: 11439363
[TBL] [Abstract][Full Text] [Related]
33. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
[TBL] [Abstract][Full Text] [Related]
34. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
35. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
Tang S; Luo H; Yu J; Yang D; Shu J
Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
[TBL] [Abstract][Full Text] [Related]
36. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
37. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA
Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771
[TBL] [Abstract][Full Text] [Related]
38. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.
Lee M; Sup Han W; Kyoung Kim O; Hee Sung S; Sun Cho M; Lee SN; Koo H
Pathol Res Pract; 2006; 202(6):415-24. PubMed ID: 16675157
[TBL] [Abstract][Full Text] [Related]
40. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
